Assessment to Identify Predictors of 2-Hour Pain Freedom among Patients Enrolled in 2 Phase 3 Studies of Lasmiditan for Acute Treatment of Migraine

被引：0
|
作者：
Vargas, Bert B. [1 ]
Magis, Delphine [2 ]
Doty, Erin [3 ]
Ruff, Dustin [3 ]
Vasudev, Raghavendra [3 ]
Krege, John H. [3 ]
Hake, Ann [3 ,4 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Dept Neurol, Dallas, TX USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Indiana Univ, Sch Med, Bloomington, IN 47405 USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1763
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Lasmiditan is Effective in the Acute Treatment of Migraine in Patients with Insufficient Response to Triptans: Findings from the Modified-parallel, Placebo-controlled, Double-blind, Phase 3 Consistency CENTURION Study
    Reuter, U.
    Lombard, L.
    Krege, J.
    Valderas, E. Gomez
    Krikke-Workel, J.
    Agnello, G. Dell
    Dowsett, S.
    Buse, D. C.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 136 - 136
  • [32] Intranasal zavegepant is effective and well tolerated for the acute treatment of migraine: A phase 2/3 dose-ranging clinical trial
    Croop, R.
    Madonia, J.
    Conway, C. M.
    Thiry, A. C.
    Forshaw, M.
    Murphy, A.
    Jensen, C. M.
    Dubowchik, G. M.
    Coric, V
    Lipton, R. B.
    [J]. HEADACHE, 2021, 61 : 104 - 105
  • [33] Intranasal Zavegepant is Effective and Well Tolerated for the Acute Treatment of Migraine: A Phase 2/3 Dose-Ranging Clinical Trial
    Lipton, R. B.
    Madonia, J.
    Conway, C. M.
    Thiry, A.
    Forshaw, M.
    Murphy, A.
    Jensen, C. M.
    Dubowchik, G.
    Coric, V.
    Croop, R.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 147 - 147
  • [34] Intranasal Zavegepant is Effective and Well Tolerated for the Acute Treatment of Migraine: A Phase 2/3 Dose-Ranging Clinical Trial
    Lipton, R. B.
    Madonia, J.
    Conway, C. M.
    Thiry, A.
    Forshaw, M.
    Murphy, A.
    Jensen, C. M.
    Dubowchik, G.
    Coric, V.
    Croop, R.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 99 - 99
  • [35] Intranasal Zavegepant is Effective and Well Tolerated for the Acute Treatment of Migraine: A Phase 2/3 Dose-Ranging Clinical trial
    Croop, Robert
    Madonia, Jennifer
    Conway, Charles
    Thiry, Alexandra
    Forshaw, Micaela
    Murphy, Abigail
    Jensen, Christopher
    Dubowchik, Gene
    Coric, Vlad
    Lipton, Richard
    [J]. NEUROLOGY, 2021, 96 (15)
  • [36] Phase 3 Studies (EVOLVE-1 & EVOLVE-2) of Galcanezumab in Episodic Migraine: Results of 6-Month Treatment Phase
    Skljarevski, Vladimir
    Stauffer, Virginia L.
    Zhang, Qi
    Detke, Holland C.
    Millen, Brian A.
    Yang, Jyun Yan
    Selzler, Katherine J.
    Conley, Robert
    Aurora, Sheena K.
    [J]. CEPHALALGIA, 2017, 37 : 339 - 340
  • [37] Phase 3 Studies (EVOLVE-1 & EVOLVE-2) of Galcanezumab in Episodic Migraine: Results of 6-Month Treatment Phase
    Skljarevski, Vladimir
    Stauffer, Virginia L.
    Zhang, Qi
    Detke, Holland C.
    Millen, Brian A.
    Yang, Jyun Yan
    Selzler, Katherine J.
    Conley, Robert
    Aurora, Sheena K.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [38] Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
    Farkkila, Markus
    Diener, Hans-Christoph
    Geraud, Gilles
    Lainez, Miguel
    Schoenen, Jean
    Harner, Nadja
    Pilgrim, Alison
    Reuter, Uwe
    [J]. LANCET NEUROLOGY, 2012, 11 (05): : 405 - 413
  • [39] Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
    Stauffer, Virginia L.
    Turner, Ira
    Kemmer, Phebe
    Kielbasa, William
    Day, Kathleen
    Port, Martha
    Quinlan, Tonya
    Camporeale, Angelo
    [J]. JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [40] Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials
    Virginia L. Stauffer
    Ira Turner
    Phebe Kemmer
    William Kielbasa
    Kathleen Day
    Martha Port
    Tonya Quinlan
    Angelo Camporeale
    [J]. The Journal of Headache and Pain, 2020, 21
12345